Clinipace Investors

16 investors on Angel Roster list Clinipace in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Series A and the largest groups are based in the United States.

Investors are matched on the company name in their portfolio, so companies that share the name Clinipace can appear together.

Investors listed
16
With verified email
75%
Most common stage
Series A
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 16 Clinipace investors

The most complete profiles first. Showing 16 of 16.

  • Ben ScruggsVerified

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceInformation Technology (IT)

    Portfolio: Standard Bariatrics, Contego Medical, Clearside Biomedical, Vigil Neuroscience and 46 more

    Verified email available

  • Douglas ReedVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedAndroidLife Science

    Portfolio: Standard Bariatrics, Contego Medical, Clearside Biomedical, Vigil Neuroscience and 46 more

    Verified email available

  • Jeff TerrellVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedAndroidLife Science

    Portfolio: Standard Bariatrics, Contego Medical, Clearside Biomedical, Vigil Neuroscience and 45 more

    Verified email available

  • John CrumplerVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedAndroidLife Science

    Portfolio: Standard Bariatrics, Contego Medical, Clearside Biomedical, Vigil Neuroscience and 47 more

    Verified email available

  • Louis BernemanVerified

    Venture Capital, University Program, Entrepreneurship Program · United States

    Series AHealth CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more

    Verified email available

  • Manny StockmanVerified

    Venture Capital, University Program, Entrepreneurship Program · United States

    Series AHealth CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more

    Verified email available

  • Robert AdelsonVerified

    Venture Capital, University Program, Investor · United States

    Series AHealth CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 65 more

    Verified email available

  • Anurag AgarwalVerified

    Venture Capital, University Program, Entrepreneurship Program · United States

    Health CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more

    Verified email available

  • Matt CohenVerified

    Venture Capital, University Program · United States

    Health CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more

    Verified email available

  • Michael DialVerified

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceInformation Technology (IT)

    Portfolio: Standard Bariatrics, Contego Medical, Clearside Biomedical, Vigil Neuroscience and 45 more

    Verified email available

  • Robert MorffVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedAndroidLife Science

    Portfolio: Standard Bariatrics, Contego Medical, Clearside Biomedical, Vigil Neuroscience and 45 more

    Verified email available

  • Kseniya Simpson, PhD

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedAndroidLife Science

    Portfolio: Standard Bariatrics, Contego Medical, Clearside Biomedical, Vigil Neuroscience and 45 more

    Contact details available

  • Marc Singer

    Venture Capital, University Program, Entrepreneurship Program · United States

    Series AHealth CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 69 more

    Contact details available

  • William Harrington

    Venture Capital, University Program, Investor · United States

    Series AHealth CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 71 more

    Contact details available

  • Kirsten Leute

    Venture Capital, University Program · United States

    Health CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more

    Contact details available

  • Kenneth LeeVerified

    Venture Capital, Angel/Individual, Investor · United States

    SeedSeries AEnterprise SoftwareArtificial Intelligence (AI)BiotechnologyElectronic Health Records (EHR)

    Portfolio: Clinverse, Clinipace

    Verified email available

Frequently asked questions

How many Clinipace investors are on Angel Roster?

Angel Roster lists 16 Clinipace investors. 12 of them (75%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (16), Private Equity Firms (9) and University Program Investors (8). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Clinipace investors invest in?

Among those that list a stage, the most common are Series A (6) and Seed (6).

Where are Clinipace investors based?

Most are based in the United States (16).

Which companies have Clinipace investors backed?

The most-backed portfolio companies among them are Artizan Biosciences (15), Atsena Therapeutics (15), Vor Biopharma (8), Millendo Therapeutics (8) and KenSci (8).

How do I contact Clinipace investors?

Create a free Angel Roster account to search and filter all 16, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.